Effect of L-Arginine and Pycnogenol on Light to Moderate Hypertension and Endothelial Function

NCT ID: NCT02392767 Phase: NA Status: COMPLETED Enrollment: 25 Completion: 2015-08

Conditions

Endothelial Dysfunction, Hyperhomocysteinemia, Hypertension Grade I, Subgroup "Borderline" (WHO)

Interventions

Verum, Placebo

Summary

The effect of a combination product (Verum ) with L-arginine, Pycnogenol, vitamin K2, R-(+)-alpha-lipoic acid and vitamins B6, B12 and folic acid is investigated in a double blind placebo-controlled cross-over study. Volunteers with hypertension and hyperhomocysteinemia are randomly assigned to the dietary supplement or placebo.

Primary Outcome

Change in Endothelial Function Between the Visit at Start of Supplementation Phase and the Visit on the Final Day of the 4 Week Supplementation Phase (Delta "lnRHI")

Source

ClinicalTrials.gov